A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

Phase 1 Completed 22 enrolled Novo Nordisk A/S

RandomizedCrossoverDouble-blindTreatment

Summary

This trial is conducted in Japan. The aim of this clinical trial is to investigate the effect of NN1250 (insulin degludec) in Japanese subjects with type 1 diabetes.

Timeline

Start: 2010-06
Primary completion: 2010-10
Completion: 2010-10

Publications

Results Ikushima I, Kaku K, Hirao K, Bardtrum L, Haahr H. Pharmacokinetic and pharmacodynamic properties of insulin degludec in Japanese patients with type 1 diabetes mellitus reflect similarities with Caucasian patients. J Diabetes Investig. 2016 Mar;7(2):270-5. doi: 10.1111/jdi.12399. Epub 2015 Aug 27.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	insulin degludec	Protein / enzyme biologic	—	Subcutaneous
Comparator	insulin detemir	Protein / enzyme biologic	—	Subcutaneous

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

Summary

Timeline

Publications

Drugs

Indications